Johnson & Johnson (BSP:JNJB34)
R$ 60.12 0 (0%) Market Cap: 2.18 Til Enterprise Value: 2.27 Til PE Ratio: 24.52 PB Ratio: 5.08 GF Score: 76/100

Johnson & Johnson at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 16, 2020 / 02:15PM GMT
Release Date Price: R$52.2 (-0.80%)
David Ryan Lewis
Morgan Stanley, Research Division - MD

I want to welcome you to Morgan Stanley Healthcare Conference 2020. Thanks for joining us here for the first 2 days, and we're excited, obviously, about the back half of the week. It is my pleasure to have with us here this morning, continuing our conference this morning, the CEO and Chairman of Johnson & Johnson, Alex Gorsky. It's always a pleasure, Alex, to be with you, and I appreciate you taking time to be with us here this morning.

Alex Gorsky
Johnson & Johnson - Chairman & CEO

Sure. Well, David, it's good to be with you today, albeit remotely, but thanks a lot for having us and I look forward to the conversation.

Questions & Answers

David Ryan Lewis
Morgan Stanley, Research Division - MD

Great. I appreciate it, Alex. So I want to start strategically, and this is one of my -- and only [been a goody], Alex, but I feel like I want to ask it again. It's funny time, right? You have all these disparate businesses. The Consumer business

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot